News & Events

News

news

17 September 2020

Da Volterra presenting an e-poster entitled “A review of meta-analyses on the impact of antibiotics on the efficacy of immune checkpoint inhibitors and cancer patients’ survival” at the ESMO Virtual Congress.

The e-poster highlights the need to develop innovative approaches to protect the intestinal microbiota of cancer patients treated with immune…

news

01 September 2020

Da Volterra Announces Positive Results from a Phase 1 Clinical Trial Evaluating DAV132 in Healthy Volunteers Receiving ß-lactam Antibiotics

• First clinical study evaluating the safety and efficacy of DAV132 in association with antibiotics from the ß-lactam class,…

news

24 August 2020

Da Volterra is attending ChinaBio® Partnering Forum Digital on August 25-27, 2020!

The event will bring together—digitally—hundreds of life science leaders for three days of productive cross-border partnering. We look forward to…

news

12 July 2020

Les Echos : Comment la biotech Da Volterra veut combattre la résistance aux antibiotiques

La biotech a mis au point un adsorbant intestinal qui capte les résidus d’antibiotiques évitant ainsi la sélection de bactéries…

news

11 June 2020

Coronavirus: les autorités sanitaires alertent contre un excès de prescriptions d’antibiotiques, confirmant ainsi le besoin pour des approches préventives telles que DAV132.

La Direction générale de la Santé, s’appuyant sur un avis du Haut conseil scientifique, a lancé l’alerte lundi via un…

news

08 June 2020

Da Volterra is attending BIO Digital on June 8-12, 2020!

The BIO International Convention is the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings…

news

04 June 2020

Da Volterra’s CEO, Florence Séjourné, part of an interactive, virtual panel discussion: “Shifting the Treatment Paradigm: New tools to tackle antimicrobial resistance” during the virtual edition of the 2020 BIO International Convention.

Moderator: Natalie Grover, Reporter, Endpoints News. Speakers: Oreola Donini, PhD, Chief Scientific Officer, Soligenix, Inc. Daria Hazuda, VP, Infectious Diseases…

Non classé

26 May 2020

New study published in the Journal of Infection Control & Hospital Epidemiology highlights the need for prevention of CDI, especially in patients with hematological malignancies

The Da Volterra team, along with fellow scientists, is glad to announce the publication of a new study in the…

news

19 May 2020

Da Volterra Announces the Publication of Four Abstracts in the 30th ECCMID Abstract Book

We are very happy to share our research with colleagues from around the world in one of the most comprehensive…

Non classé

21 April 2020

Da Volterra to present ‘The Perception of Quality of Life Among CDI Patients in the US’ at Peggy Lillis Foundation’ 2020 National C. diff Advocacy Summit on April 21 at 1:10pm EST

Lise Lurienne, Market Access Manager at Da Volterra, together with Pierre-Alain Bandinelli, Da Volterra CBO, presented the subject of quality…